Comparative Pharmacology
Head-to-head clinical analysis: PHENAPHEN 650 W CODEINE versus PHENAPHEN W CODEINE NO 3.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PHENAPHEN 650 W CODEINE versus PHENAPHEN W CODEINE NO 3.
PHENAPHEN-650 W/ CODEINE vs PHENAPHEN W/ CODEINE NO. 3
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Acetaminophen: Weak COX-1 and COX-2 inhibitor in CNS, antipyretic via hypothalamic heat-regulating center. Codeine: Prodrug converted to morphine; mu-opioid receptor agonist.
Codeine is an opioid agonist that binds to mu-opioid receptors, inhibiting adenylate cyclase and reducing cAMP production, leading to decreased neurotransmitter release and modulation of pain perception. Acetaminophen produces analgesia through central cyclooxygenase (COX) inhibition and activation of descending serotonergic pathways.
Acetaminophen 650 mg and codeine 60 mg orally every 4 hours as needed for pain; maximum acetaminophen 3 g/day.
One to two tablets (30-60 mg codeine phosphate/300-600 mg acetaminophen) orally every 4 hours as needed for pain, maximum 12 tablets per day.
None Documented
None Documented
Acetaminophen: 2-3 hours (normal liver function); prolonged in liver disease (up to 5-10 hours) or overdose. Codeine: 2.5-3.5 hours; active metabolite morphine ~2 hours. Clinical context: half-life affects dosing interval; accumulation in hepatic or renal impairment.
Codeine: terminal elimination half-life is 2.5–3.5 hours in healthy adults; morphine: 1.5–4.5 hours; morphine-6-glucuronide: 2.5–4.5 hours. Half-life is prolonged in hepatic or renal impairment; in end-stage renal disease, half-life of codeine and metabolites may exceed 24 hours.
Acetaminophen: renal excretion of conjugates (glucuronide ~55%, sulfate ~30%, cysteine/mercapturate ~4%), with <5% unchanged. Codeine: renal excretion as codeine (~10%), norcodeine (~10%), morphine (~10%), and their conjugates; total 70-90% in urine as glucuronide conjugates.
Renal excretion of codeine and its metabolites (morphine, norcodeine, codeine-6-glucuronide, morphine-3-glucuronide, morphine-6-glucuronide). Approximately 80-90% of the dose is eliminated in urine within 24 hours, with about 10% as unchanged codeine, 10% as norcodeine, 10% as free and conjugated morphine, and the remainder as conjugated codeine and other metabolites. Fecal excretion accounts for less than 10%.
Category D/X
Category D/X
Opioid Agonist
Opioid Agonist